Bilateral Retinal Angiomatous Proliferation in a Variant of Retinitis Pigmentosa

被引:5
作者
Aloe, G. [1 ]
De Sanctis, C. M. [1 ]
Strafella, C. [2 ,3 ]
Cascella, R. [3 ,4 ]
Missiroli, F. [1 ]
Cesareo, M. [1 ]
Giardina, E. [2 ,3 ]
Ricci, F. [1 ]
机构
[1] Tor Vergata Univ, PTV Fdn, Unit Retinal Pathol, Rome, Italy
[2] Tor Vergata Univ, Dept Biomed & Prevent, Rome, Italy
[3] Santa Lucia Fdn, Mol Genet Lab UILDM, Rome, Italy
[4] Catholic Univ Our Lady Good Counsel, Dept Biomed Sci, Tirana, Albania
关键词
ANGIOGRAPHY; OCT;
D O I
10.1155/2019/8547962
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
Purpose. To describe the first case of bilateral retinal angiomatous proliferation (RAP) in a patient with a variant of retinitis pigmentosa (RP). Case Report. An 85-year-old man with RP presented with visual acuity decrease and metamorphopsia in the left eye (LE). Fundus examination revealed typical signs of RP in both eyes, associated with intraretinal macular hemorrhage in the LE. Multimodal imaging, using Colour fundus Photography, Fluorescein (FA), and Indocyanine Green Angiography (ICGA) as well as Spectral-Domain Optical Coherence Tomography (SD-OCT) and Optical Coherence Tomography Angiography (OCTA), revealed a type 3 neovascular lesion in the involved eye. Genetic testing (NGS analysis) was performed to search for genetic variants correlated with the disease phenotype displayed by the patient. The patient was treated with intravitreal injections of bevacizumab, according to a fixed protocol of bimonthly injections plus a booster dose at second month. After 9 months, he was referred for visual acuity decrease and metamorphopsia in the fellow eye, where SD-OCT/OCTA showed a type 3 neovascular lesion in the right eye (RE). He was scheduled for intravitreal injections of bevacizumab. In both eyes, treatment with intravitreal bevacizumab was successful.
引用
收藏
页数:5
相关论文
共 21 条
[1]  
Brancato R, 2002, EUR J OPHTHALMOL, V12, P467, DOI 10.5301/EJO.2008.2283
[2]   Assessing individual risk for AMD with genetic counseling, family history, and genetic testing [J].
Cascella, R. ;
Strafella, C. ;
Longo, G. ;
Manzo, L. ;
Ragazzo, M. ;
De Felici, C. ;
Gambardella, S. ;
Marsella, L. T. ;
Novelli, G. ;
Borgiani, P. ;
Sangiuolo, F. ;
Cusumano, A. ;
Ricci, F. ;
Giardina, E. .
EYE, 2018, 32 (02) :446-450
[3]   Towards the application of precision medicine in Age-Related Macular Degeneration [J].
Cascella, Raffaella ;
Strafella, Claudia ;
Caputo, Valerio ;
Errichiello, Valeria ;
Zampatti, Stefania ;
Milano, Filippo ;
Potenza, Saverio ;
Mauriello, Silvestro ;
Novelli, Giuseppe ;
Ricci, Federico ;
Cusumano, Andrea ;
Giardina, Emiliano .
PROGRESS IN RETINAL AND EYE RESEARCH, 2018, 63 :132-146
[4]  
Cascella Raffaella, 2018, Oncotarget, V9, P7812, DOI 10.18632/oncotarget.23241
[5]   The Genetics and the Genomics of Primary Congenital Glaucoma [J].
Cascella, Raffaella ;
Strafella, Claudia ;
Germani, Chiara ;
Novelli, Giuseppe ;
Ricci, Federico ;
Zampatti, Stefania ;
Giardina, Emiliano .
BIOMED RESEARCH INTERNATIONAL, 2015, 2015
[6]  
Cascella R, 2015, PHARMACOGENOMICS, V16, P1039, DOI [10.2217/PGS.15.59, 10.2217/pgs.15.59]
[7]  
Cheng Jacob Yen Chuang, 2009, Retin Cases Brief Rep, V3, P388, DOI 10.1097/ICB.0b013e31817f2e3f
[8]   En face OCT angiography demonstrates flow in early type 3 neovascularization (retinal angiomatous proliferation) [J].
Dansingani, K. K. ;
Naysan, J. ;
Freund, K. B. .
EYE, 2015, 29 (05) :703-706
[9]   Retinitis pigmentosa [J].
Hamel, Christian .
ORPHANET JOURNAL OF RARE DISEASES, 2006, 1 (1)
[10]   The role of Sema4A in angiogenesis, immune responses, carcinogenesis, and retinal systems [J].
Ito, Daisuke ;
Kumanogoh, Atsushi .
CELL ADHESION & MIGRATION, 2016, 10 (06) :692-699